Medicus Pharma Ltd.
MDCX · XNASCIK 1997296fmd_0FCYVM5K1778YGRWFWWB0TJ1K3Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2023 to Sep 30, 2026, 12 periods
| Line item | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Net interest income | – | 0 | (0) |
| Research and development | 0 | 4 | 8 |
| Total operating expenses | 5 | 11 | 34 |
| Operating income | (5) | (11) | (34) |
| Other non-operating income (expense) | (1) | 0 | (1) |
| Income before taxes | (5) | (11) | (35) |
| Income tax expense | 0 | 0 | 0 |
| Net income from continuing operations | (5) | (11) | (35) |
| Net income | (5) | (11) | (47) |
| Net income to common shareholders | (5) | (11) | (47) |